Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Gladstone Institute of Virology, The J. David Gladstone Institutes, San Francisco, CA, USA.
Nat Commun. 2022 Sep 8;13(1):5282. doi: 10.1038/s41467-022-32758-3.
Enteroviruses cause a number of medically relevant and widespread human diseases with no approved antiviral therapies currently available. Host-directed therapies present an enticing option for this diverse genus of viruses. We have previously identified the actin histidine methyltransferase SETD3 as a critical host factor physically interacting with the viral protease 2A. Here, we report the 3.5 Å cryo-EM structure of SETD3 interacting with coxsackievirus B3 2A at two distinct interfaces, including the substrate-binding surface within the SET domain. Structure-function analysis revealed that mutations of key residues in the SET domain resulted in severely reduced binding to 2A and complete protection from enteroviral infection. Our findings provide insight into the molecular basis of the SETD3-2A interaction and a framework for the rational design of host-directed therapeutics against enteroviruses.
肠道病毒引起许多具有重要医学意义和广泛流行的人类疾病,但目前尚无批准的抗病毒疗法。宿主定向疗法为这一多样化的病毒属提供了一个诱人的选择。我们之前已经确定肌动蛋白组氨酸甲基转移酶 SETD3 是与病毒蛋白酶 2A 物理相互作用的关键宿主因子。在这里,我们报告了 SETD3 与柯萨奇病毒 B3 2A 在两个不同界面相互作用的 3.5Å 冷冻电镜结构,包括 SET 结构域内的底物结合表面。结构功能分析表明,SET 结构域中关键残基的突变导致与 2A 的结合严重减少,并完全防止肠道病毒感染。我们的发现为 SETD3-2A 相互作用的分子基础提供了深入了解,并为针对肠道病毒的宿主定向治疗的合理设计提供了框架。